↓ Skip to main content

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Readers on

mendeley
137 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Obinutuzumab (GA101) Monotherapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma or Mantle-Cell Lymphoma: Results From the Phase II GAUGUIN Study
Published in
Journal of Clinical Oncology, July 2013
DOI 10.1200/jco.2012.46.9585
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 137 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Ecuador 2 1%
United States 1 <1%
United Kingdom 1 <1%
Germany 1 <1%
Unknown 132 96%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Researcher 41 30%
Student > Ph. D. Student 16 12%
Other 15 11%
Student > Bachelor 13 9%
Professor > Associate Professor 10 7%
Other 29 21%
Unknown 13 9%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 73 53%
Agricultural and Biological Sciences 16 12%
Pharmacology, Toxicology and Pharmaceutical Science 7 5%
Biochemistry, Genetics and Molecular Biology 5 4%
Unspecified 4 3%
Other 12 9%
Unknown 20 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2019.
All research outputs
#2,390,308
of 34,089,221 outputs
Outputs from Journal of Clinical Oncology
#6,707
of 32,061 outputs
Outputs of similar age
#17,297
of 238,592 outputs
Outputs of similar age from Journal of Clinical Oncology
#59
of 239 outputs
Altmetric has tracked 34,089,221 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,061 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,592 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.